Filter
1702
Text search:
national
drug
authority
Featured
132
566
Language
Document type
1083
232
203
79
57
18
16
8
2
2
1
1
Countries / Regions
98
80
70
67
47
46
44
41
41
41
35
35
35
32
31
28
26
26
23
23
22
21
19
18
17
14
14
13
10
10
10
9
9
8
7
7
6
6
6
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
846
95
73
49
36
30
24
2
Toolboxes
133
117
113
108
105
64
51
31
26
26
26
25
23
20
18
17
9
9
8
8
7
7
2
Capability and Performance
10–21 March 2014
Strategy for Increasing the use of Modern Contraceptives in Nigeria
The National Health Plan (NHP) aims to strengthen the country’s health system and pave the way towards Universal Health Coverage (UHC),choosing a path that is explicitly pro-poor. The main goal of NHP 2017-2021 is to extend access to a Basic Essen
...
An update from the EU Early Warning System
Endorsed by the CCM Georgia on April 15th 2015
Accessed: 26.09.2019
AMR is a serious and growing global problem. A WHO report released in 2014 stated that this serious threat is no longer a prediction for the future it is happening now in every region of the world and has potential to affect anyone, of any age in any community – a real threat to the public health.
...
Antimicrobial resistance (AMR) has become a global public health concern and Lebanon is of no exception to this issue. The spread of antimicrobial-resistant bacteria is considered an alarming public health threat, with a potential extent similar to global warming and other social and environmental t
...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audien
...
The goals and objectives of the Sudan National Action Plan on AMR can only be achieved through implementing strategic interventions and activities with all concerned ministries and departments joining hands with other stakeholders to collaboratively
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of
...
